Paper12399596
Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.
Aarts M and 8 others. Science, 2002. Cited by 855 papers, by iCite.
Cite this record
ConductScience Library. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Papers, record 12399596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12399596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics29
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Brain Ischemia | Major topic |
| Cerebral Infarction | Major topic |
| Nerve Tissue Proteins | Major topic |
| Peptides | Major topic |
| Receptors, N-Methyl-D-Aspartate | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Calcium | |
| Cells, Cultured | |
| Cyclic GMP | |
| Disks Large Homolog 4 Protein | |
| Guanylate Kinases | |
| In Vitro Techniques | |
| Intracellular Signaling Peptides and Proteins | |
| Male | |
| Membrane Proteins | |
| Mice | |
| Mice, Inbred C57BL | |
| N-Methylaspartate | |
| Neurons | |
| Patch-Clamp Techniques | |
| Protein Binding | |
| Rats | |
| Rats, Sprague-Dawley | |
| Rats, Wistar | |
| Recombinant Fusion Proteins | |
| Signal Transduction | |
| Synaptic Transmission |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NS 39060 | NINDS NIH HHS | United States | R01NS039060 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02930018 | Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke | Background |
Source ClinicalTrials.gov
Cited by426
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 855 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984968 | Brain cytoprotection in acute ischemic stroke in the reperfusion era: neuroimmune networks, clinical evidence, and translational barriers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42984968 | PubMed |
| 42666667 | Gap junction protein connexin 36 proteostatic mechanisms in photoreceptor cells subjected to excitotoxic stress. | Acta Biochim Pol | 2026 | https://conductscience.org/library/papers/42666667 | PubMed |
| 42346449 | Advances in Reperfusion Therapy and Cytoprotection for Acute Ischemic Stroke. | J Cardiovasc Dev Dis | 2026 | https://conductscience.org/library/papers/42346449 | PubMed |
| 42333641 | Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/42333641 | PubMed |
| 42134332 | Recombinant dimeric PICK1 peptide inhibitors for long-term relief of chronic pain by AAV therapeutics. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42134332 | PubMed |
| 41400652 | Efficacy and safety of intravenous nerinetide in acute ischemic stroke patients undergoing endovascular thrombectomy without thrombolysis: a meta-analysis of randomized controlled trials. | Neuroradiology | 2026 | https://conductscience.org/library/papers/41400652 | PubMed |
| 41398232 | Elevated circulation postsynaptic density protein 95 as a potential biomarker for predicting the diagnosis and prognosis of acute cerebral infarction. | BMC Neurol | 2025 | https://conductscience.org/library/papers/41398232 | PubMed |
| 41343242 | Protein-protein interaction-interfering peptide rescues dysregulated NMDA receptor signaling. | JCI Insight | 2026 | https://conductscience.org/library/papers/41343242 | PubMed |
| 41188625 | New advances in small molecule drugs targeting NMDA receptors. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/41188625 | PubMed |
| 41026285 | The Impact of Glutamatergic Excitotoxicity on the Differentiation of Cerebellar Neural Stem Cells. | J Mol Neurosci | 2025 | https://conductscience.org/library/papers/41026285 | PubMed |
| 41002036 | Back Again to the Future: A New Era for Cerebroprotection. | Ann Neurol | 2026 | https://conductscience.org/library/papers/41002036 | PubMed |
| 40971139 | Microglial Polarization and Therapeutic Strategies in Post-stroke Neuroinflammation. | Neurol Ther | 2025 | https://conductscience.org/library/papers/40971139 | PubMed |
| 40880478 | Excitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels. | Sci Adv | 2025 | https://conductscience.org/library/papers/40880478 | PubMed |
| 40776985 | Tat-NR2B9c prevent cognitive dysfunction in mice modeling Alzheimer's Disease induced by Aβ1-42 via perturbing PSD-95 interactions with NR2B-subtype receptors. | IBRO Neurosci Rep | 2025 | https://conductscience.org/library/papers/40776985 | PubMed |
| 40713246 | Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/40713246 | PubMed |
| 40692378 | A Molecular Recruitment Colocalization Platform for Visualizing Multi-Protein Interactions and Engineering Biomolecular Condensates in Living Cells. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40692378 | PubMed |
| 40566537 | How to Pick a Neuroprotective Drug in Stroke Without Losing Your Mind? | Life (Basel) | 2025 | https://conductscience.org/library/papers/40566537 | PubMed |
| 40379866 | Soluble TREM2 ameliorates pathological phenotypes in ischemic stroke models via modulating neuronal and microglial functions. | Exp Brain Res | 2025 | https://conductscience.org/library/papers/40379866 | PubMed |
| 40225562 | A brain-accessible peptide modulates stroke inflammatory response and neurotoxicity by targeting BDNF-receptor TrkB-T1 specific interactome. | Theranostics | 2025 | https://conductscience.org/library/papers/40225562 | PubMed |
| 40180762 | The PSD-95 inhibitor NA-1 is delivered to the brain upon nasal administration with uptake into the olfactory bulb improved by co-administration with the cell-penetrating peptides lowPro and Tat. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/40180762 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12399596
GET https://conductscience.org/api/papers/v1/12399596/cited_by?page=2